The reiteration of a Buy rating and a maintained price target by a reputable analyst like Gil Blum from Needham is likely to instill confidence among investors and could lead to a positive short-term impact on Autolus Therapeutics' stock price. Analyst ratings, especially with a Buy recommendation, tend to influence market perception and investor sentiment positively.